Loss of Tid1/Dnaja3 co-chaperone promotes progression and recurrence of hepatocellular carcinoma after surgical resection: A novel model to stratify risk of recurrence

Kuan Yang Chen, Yi Hsiang Huang, Wan Huai Teo, Ching Wen Chang, Yu Syuan Chen, Yi Chen Yeh, Chieh Ju Lee, Jeng Fan Lo

研究成果: 雜誌貢獻文章同行評審

5 引文 斯高帕斯(Scopus)

摘要

Tid1, a mitochondrial co-chaperone protein, acts as a tumor suppressor in various cancer types. However, the role of Tid1 in hepatocellular carcinoma (HCC) remains unclear. First, we found that a low endogenous Tid1 protein level was observed in poorly differentiated HCC cell lines. Further, upregulation/downregulation of Tid1 abrogated/promoted the malignancy of human HCC cell lines, respectively. Interestingly, Tid1 negatively modulated the protein level of Nrf2. Tissue assays from 210 surgically resected HCC patients were examined by immunohistochemistry (IHC) analyses. The protein levels of Tid1 in the normal and tumor part of liver tissues were correlated with the clinical outcome of the 210 HCC cases. In multivariate analysis, we discovered that tumor size > 5 cm, multiple tumors, presence of vascular invasion, low Tid1 expression in the non-tumor part, and high Nrf2 expression in the non-tumor part were significant factors associated with worse recurrence-free survival (RFS). A scoring system by integrating the five clinical and pathological factors predicts the RFS among HCC patients after surgical resection. Together, Tid1, serving as a tumor suppressor, has a prognostic role for surgically resected HCC to predict RFS.
原文英語
文章編號138
頁(從 - 到)1-15
頁數15
期刊Cancers
13
發行號1
DOIs
出版狀態已發佈 - 1月 2021
對外發佈

ASJC Scopus subject areas

  • 腫瘤科
  • 癌症研究

指紋

深入研究「Loss of Tid1/Dnaja3 co-chaperone promotes progression and recurrence of hepatocellular carcinoma after surgical resection: A novel model to stratify risk of recurrence」主題。共同形成了獨特的指紋。

引用此